Analytical testing confirms 99.8 % purity , assay content verified at 5.51 mg, molecular ion mass identified at 848 Da and endotoxin levels measured at 0.020 EU/mg
mean 6.5 years), ensuring diagnostic reliability and appropriate use of the Childhood Autism Rating Scale (CARS)
however, the safety profile of semaglutide in each SUSTAIN and PIONEER trial individually has previously been reported.16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33 The limitations of our analysis include the low number of CV events and the short trial durations of SUSTAIN 6 (planned exposure 104 weeks and median followup 2.1 years) and PIONEER 6 (median followup 1.3 years) compared with other CVOTs
2021;9:e1113